Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
READ Act (H.R. 10031 / S. 4689
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · third_quarter · Q3
CDC Reform
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| ENDOCRINE SOCIETY |
| 3 |
| 2023–2024 |
| AMERICAN SOCIETY OF PEDIATRIC NEPHROLOGY | 1 | 2023 |
| THE MYOSITIS ASSOCIATION | 1 | 2026 |
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
READ Act (H.R. 10031 / S. 4689
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act
Reducing Medically Unnecessary Delays in Care Act of 2025
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRE-HOSPITAL STROKE TREATMENT ORGANIZATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRE-HOSPITAL STROKE TREATMENT ORGANIZATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRE-HOSPITAL STROKE TREATMENT ORGANIZATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRE-HOSPITAL STROKE TREATMENT ORGANIZATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRE-HOSPITAL STROKE TREATMENT ORGANIZATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRE-HOSPITAL STROKE TREATMENT ORGANIZATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 721 Sickle Cell Disease Comprehensive Care Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 721 Sickle Cell Disease Comprehensive Care Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR7432, Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR7432, Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model
Cancer Drug Parity Act of 2023
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
Cancer Drug Parity Act of 2023
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
Cancer Drug Parity Act of 2023
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 2039//H.R. 6301, the Cancer Drug Parity Act; Cancer Moonshot
Cancer Drug Parity Act of 2023
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 2039//H.R. 6301, the Cancer Drug Parity Act; Cancer Moonshot
Cancer Drug Parity Act of 2023
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
Cancer Drug Parity Act of 2023
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
2026 · third_quarter · Q3
Research funding for myositis at the Department of Defense (DoD) (through the CDMRP)
Research funding for myositis at the National Institutes of Health (NIH) and Department of Defense (DoD) (through the CDMRP)
Presumptive disability benefit status for veterans diagnosed with Inclusion Body Myositis (IBM).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REACH OUT & READ via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · third_quarter · Q3
FY27 Labor, Health and Human Services Appropriations Bill; Continuing Resolution
READ Act (H.R. 10031 / S. 4689
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · third_quarter · Q3
FY 2027 funding for TB programs at DOD, NIH, and USAID
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · second_quarter · Q2
FY 2027 funding for TB programs at DOD, NIH, and USAID
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REACH OUT & READ via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · second_quarter · Q2
FY27 Labor, Health and Human Services Appropriatons Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · second_quarter · Q2
CDC Reform
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · first_quarter · Q1
FY26 and FY27 funding for TB Programs at DOD, NIH and USAID
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · first_quarter · Q1
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REACH OUT & READ via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 · first_quarter · Q1
FY27 Labor HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · fourth_quarter · Q4
FY26 funding for TB Programs at DoD, NIH and USAID
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · fourth_quarter · Q4
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · fourth_quarter · Q4
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REACH OUT & READ via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · fourth_quarter · Q4
FY26 Labor HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · third_quarter · 3A
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · third_quarter · Q3
HR 5304/S 2587, FY26 Labor HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · third_quarter · Q3
HR 5178/S 721, Sickle Cell Disease Comprehensive Care Act; HR 2433, Reducing Medically Unnecessary Delays in Care Act of 2025; HR 1, One Big Beautiful Bill Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REACH OUT & READ via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · third_quarter · Q3
FY26 Labor HHS Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · third_quarter · Q3
FY26 funding for TB Programs at DoD, NIH and USAID
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · second_quarter · Q2
Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · second_quarter · Q2
S. 721 Sickle Cell Disease Comprehensive Care Act
Sickle Cell Disease Comprehensive Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · second_quarter · Q2
FY26 funding for TB Programs at DoD, NIH and USAID
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · first_quarter · Q1
Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · first_quarter · Q1
S. 721 Sickle Cell Disease Comprehensive Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2025 · first_quarter · Q1
FY26 funding for TB Programs at DoD, NIH and USAID
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · fourth_quarter · Q4
FY25 funding for TB programs
USAID Tuberculosis program reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · fourth_quarter · Q4
Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · fourth_quarter · Q4
GAO Study on mobile stroke units and HRSA grant program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · fourth_quarter · Q4
HR7432, Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REACH OUT & READ via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · fourth_quarter · Q4
Early Literacy during a Well-Child visit
Innovative Appraoches to Literacy Program
FY25 Labor, HHS Appropriations bill; Innovative Appraoches to Literacy Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · third_quarter · Q3
FY 2023 Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · third_quarter · Q3
GAO Study on mobile stroke units and HRSA grant program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · third_quarter · Q3
HR7432, Sickle Cell Disease Comprehensive Care Act; Social Security Disability Insurance Reform; Sickle Cell Disease - comprehensive care and cell and gene therapy model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · third_quarter · Q3
FY25 funding for TB programs
USAID Tuberculosis program reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REACH OUT & READ via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · third_quarter · Q3
Innovative Appraoches to Literacy Program
FY25 Labor, HHS Appropriations bill; Innovative Appraoches to Literacy Program
Early Literacy during a Well-Child visit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · second_quarter · Q2
FY 2023 Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · second_quarter · Q2
FY25 funding for TB programs
USAID Tuberculosis program reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · second_quarter · Q2
GAO Study on mobile stroke units
GAO Study on mobile stroke units and HRSA grant program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · first_quarter · Q1
GAO Study on mobile stroke units and HRSA grant program
GAO Study on mobile stroke units
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · second_quarter · 2T
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
FY24 Labor Health Human Services and Related Agencies
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PRE-HOSPITAL STROKE TREATMENT ORGANIZATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · first_quarter · RR
Seeking medicare reimbursement solution for mobile stroke units
INTERNATIONAL MYELOMA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · first_quarter · Q1
FY24 Labor Health Human Services and Related Agencies
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · first_quarter · Q1
FY25 funding for TB programs
USAID Tuberculosis program reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · first_quarter · Q1
Transgender health
Filing targets: Food & Drug Administration (FDA)
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2024 · first_quarter · Q1
FY 2023 Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · fourth_quarter · Q4
FY2024 funding for the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · fourth_quarter · Q4
FY 2023 Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · fourth_quarter · Q4
FY24 Labor Health Human Services and Related Agencies
S. 2039//H.R. 6301, the Cancer Drug Parity Act; Cancer Moonshot
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
ENDOCRINE SOCIETY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · third_quarter · Q3
FY2024 funding for the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF PEDIATRIC NEPHROLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · third_quarter · Q3
ESRD Bundled Payment/QIP, specifically pediatric ESRD payment; Immunosuppressive Drug Coverage for children
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · third_quarter · Q3
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
FY24 Labor Health Human Services and Related Agencies
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · third_quarter · Q3
FY 2023 Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · second_quarter · Q2
FY 2023 Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · second_quarter · Q2
S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
FY24 Labor Health Human Services and Related Agencies
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
LUPUS RESEARCH ALLIANCE via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2023 · first_quarter · Q1
FY 2023 Appropriations for LHHS and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE